Cargando…

Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up

INTRODUCTION: We studied the costs of formal and informal care in relation to Alzheimer’s disease (AD) progression. METHODS: 231 persons with AD with a family caregiver were followed up for 5 years. The Clinical Dementia Rating Scale—Sum of Boxes (CDR-SB) was used to measure AD progression. Health a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jetsonen, Viivi, Kuvaja-Köllner, Virpi, Välimäki, Tarja, Selander, Tuomas, Martikainen, Janne, Koivisto, Anne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581391/
https://www.ncbi.nlm.nih.gov/pubmed/34255025
http://dx.doi.org/10.1093/ageing/afab144
_version_ 1784596797796122624
author Jetsonen, Viivi
Kuvaja-Köllner, Virpi
Välimäki, Tarja
Selander, Tuomas
Martikainen, Janne
Koivisto, Anne M
author_facet Jetsonen, Viivi
Kuvaja-Köllner, Virpi
Välimäki, Tarja
Selander, Tuomas
Martikainen, Janne
Koivisto, Anne M
author_sort Jetsonen, Viivi
collection PubMed
description INTRODUCTION: We studied the costs of formal and informal care in relation to Alzheimer’s disease (AD) progression. METHODS: 231 persons with AD with a family caregiver were followed up for 5 years. The Clinical Dementia Rating Scale—Sum of Boxes (CDR-SB) was used to measure AD progression. Health and social care unit costs were used for formal care costs. An opportunity cost method for lost leisure time was applied to analyse the cost of informal care. RESULTS: Total cost of care in early stage AD (CDR-SB ≤ 4) was 16,448€ (95% CI 13,722–19,716) annually. In mild (CDR-SB 4.5–9), moderate (CDR-SB 9.5–15.5) and severe (CDR-SB ≥ 16) AD, the total costs were 2.3, 3.4 and 4.4 times higher, respectively. A one-unit increase in CDR-SB increased the total, formal and informal costs by 15, 11 and 18%, respectively. CONCLUSIONS: Compared to early AD, the costs of total, formal and informal care are remarkably higher already in mild AD. This finding emphasises early diagnosis, interventions and family support for persons with AD and their caregivers.
format Online
Article
Text
id pubmed-8581391
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85813912021-11-12 Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up Jetsonen, Viivi Kuvaja-Köllner, Virpi Välimäki, Tarja Selander, Tuomas Martikainen, Janne Koivisto, Anne M Age Ageing Research Paper INTRODUCTION: We studied the costs of formal and informal care in relation to Alzheimer’s disease (AD) progression. METHODS: 231 persons with AD with a family caregiver were followed up for 5 years. The Clinical Dementia Rating Scale—Sum of Boxes (CDR-SB) was used to measure AD progression. Health and social care unit costs were used for formal care costs. An opportunity cost method for lost leisure time was applied to analyse the cost of informal care. RESULTS: Total cost of care in early stage AD (CDR-SB ≤ 4) was 16,448€ (95% CI 13,722–19,716) annually. In mild (CDR-SB 4.5–9), moderate (CDR-SB 9.5–15.5) and severe (CDR-SB ≥ 16) AD, the total costs were 2.3, 3.4 and 4.4 times higher, respectively. A one-unit increase in CDR-SB increased the total, formal and informal costs by 15, 11 and 18%, respectively. CONCLUSIONS: Compared to early AD, the costs of total, formal and informal care are remarkably higher already in mild AD. This finding emphasises early diagnosis, interventions and family support for persons with AD and their caregivers. Oxford University Press 2021-07-10 /pmc/articles/PMC8581391/ /pubmed/34255025 http://dx.doi.org/10.1093/ageing/afab144 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Paper
Jetsonen, Viivi
Kuvaja-Köllner, Virpi
Välimäki, Tarja
Selander, Tuomas
Martikainen, Janne
Koivisto, Anne M
Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
title Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
title_full Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
title_fullStr Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
title_full_unstemmed Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
title_short Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
title_sort total cost of care increases significantly from early to mild alzheimer’s disease: 5-year alsova follow-up
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581391/
https://www.ncbi.nlm.nih.gov/pubmed/34255025
http://dx.doi.org/10.1093/ageing/afab144
work_keys_str_mv AT jetsonenviivi totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup
AT kuvajakollnervirpi totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup
AT valimakitarja totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup
AT selandertuomas totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup
AT martikainenjanne totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup
AT koivistoannem totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup